한국뇌졸중진료지침에서 아스피린의 뇌졸중 일차예방효과에 관한 내용의 부분개정
Focused Update on Aspirin for Primary Stroke Prevention in Korean Clinical Practice Guidelines for Stroke
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The first edition of the Korean clinical practice guidelines for primary stroke prevention reflects evidence published before June 2007. Since then, several clinical studies and meta-analyses have been conducted to determine the efficacy of aspirin for the primary prevention of cardiovascular disease including stroke. The aim of this guideline update is to provide timely recommendations taking into consideration the new evidence. Three clinical studies and four meta-analyses performed between July 2007 and November 2010 were identified and included for updating the guidelines. The main finding was a lack of aspirin efficacy for primary stroke prevention in patients with diabetes or peripheral arterial disease. We have summarized the new evidence and revised our recommendations for aspirin for primary stroke prevention. New evidence will need to be reflected continuously in future guideline updates.
Abstract
The first edition of the Korean clinical practice guidelines for primary stroke prevention reflects evidence published before June 2007. Since then, several clinical studies and meta-analyses have been conducted to determine the efficacy of aspirin for the primary prevention of cardiovascular disease including stroke. The aim of this guideline update is to provide timely recommendations taking into consideration the new evidence. Three clinical studies and four meta-analyses performed between July 2007 and November 2010 were identified and included for updating the guidelines. The main finding was a lack of aspirin efficacy for primary stroke prevention in patients with diabetes or peripheral arterial disease. We have summarized the new evidence and revised our recommendations for aspirin for primary stroke prevention. New evidence will need to be reflected continuously in future guideline updates.
참고문헌 (21)
- The writing group of clinical practice guideline for stroke, "Clinical Practice Guideline for Stroke. 1st ed" (2009), Seoul: Clinical Research Center for Stroke
- Belch J, "The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease", BMJ, 337, pp.1840~ (2008)
- Ogawa H, "Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial", JAMA, 300, pp.2134~2141 (2008)
- Baigent C, "Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials", Lancet, 373, pp.1849~1860 (2009)
- Berger JS, "Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials", JAMA, 301, pp.1909~1919 (2009)
- De Berardis G, "Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials", BMJ, 339, pp.4531~ (2009)
- Fowkes FG, "Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial", JAMA, 303, pp.841~848 (2010)
- Zhang C, "Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis", Diabetes Res Clin Pract, 87, pp.211~218 (2010)
- Goldstein LB, "Guidelines for the Primary Prevention of Stroke. A Guideline for Healthcare Professionals From the American Heart Association", American Stroke Association, 2011, pp.42, 517~584
- Ridker PM, "A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women", N Engl J Med, 352, pp.1293~1304 (2005)
- Hansson L, "Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group", Lancet, 351, pp.1755~1762 (1998)
- Peto R, "Randomised trial of prophylactic daily aspirin in British male doctors", Br Med J (Clin Res Ed), 296, pp.313~316 (1988)
- "Final report on the aspirin component of the ongoing Physicians' Health Study", N Engl J Med, 321, pp.129~135 (1989), Steering Committee of the Physicians' Health Study Research Group
- "Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework", Lancet, 351, pp.233~241 (1998)
- de Gaetano G, "Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project", Lancet, 357, pp.89~95 (2001)
- Hart RG, "Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses", Arch Neurol, 57, pp.326~332 (2000)
- Berger JS, "Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials", JAMA, 295, pp.306~313 (2006)
- Leys D, "Prevention. European stroke initiative", Cerebrovasc Dis, 17(2), pp.15~29 (2004)
- Goldstein LB, "Primary prevention of ischemic stroke: a guideline from the American Heart Association", American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline, 2006, pp.37, 1583~1633
- Bartolucci AA, "Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin", Am J Cardiol, 98, pp.746~750 (2006)
- "Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators", JAMA, 268, pp.1292~1300 (1992)